Clinically Important Benefits in Infants and Young Children with Moderate-to-Severe Atopic Dermatitis Not Achieving IGA 0/1 After 16 Weeks of Dupilumab Treatment
Authors: Amy S. Paller, Elaine C. Siegfried, Benjamin Lockshin, Amy Praestgaard, Brad Shumel, Randy Prescilla
< PREVIOUS POSTER NEXT POSTER >
